SCIO DIAMOND TECHNOLOGY CORP, 10-Q filed on 8/19/2014
Quarterly Report
Document and Entity Information
3 Months Ended
Jun. 30, 2014
Aug. 8, 2014
Document and Entity Information
 
 
Entity Registrant Name
Scio Diamond Technology Corp 
 
Entity Central Index Key
0001488934 
 
Document Type
10-Q 
 
Document Period End Date
Jun. 30, 2014 
 
Amendment Flag
false 
 
Current Fiscal Year End Date
--03-31 
 
Entity Current Reporting Status
Yes 
 
Entity Filer Category
Smaller Reporting Company 
 
Entity Common Stock, Shares Outstanding
 
50,619,312 
Document Fiscal Year Focus
2015 
 
Document Fiscal Period Focus
Q1 
 
CONDENSED BALANCE SHEETS (USD $)
Jun. 30, 2014
Mar. 31, 2014
Current Assets:
 
 
Cash and cash equivalents
$ 2,046 
$ 47,987 
Accounts receivable, net
38,796 
42,085 
Other receivables
 
89,192 
Inventory, net
185,908 
152,817 
Prepaid expenses
27,611 
79,078 
Prepaid rent
23,050 
23,050 
Total current assets
277,411 
434,209 
Property, plant and equipment
 
 
Facility
899,499 
899,499 
Manufacturing equipment
3,184,809 
3,171,656 
Other equipment
71,059 
71,059 
Total property, plant and equipment
4,155,367 
4,142,214 
Less accumulated depreciation
(1,184,252)
(1,029,212)
Net property, plant and equipment
2,971,115 
3,113,002 
Intangible assets, net
9,047,139 
9,240,640 
Prepaid rent, noncurrent
36,525 
42,288 
Other assets
20,000 
20,000 
TOTAL ASSETS
12,352,190 
12,850,139 
Current Liabilities:
 
 
Notes payable
1,473,345 
1,412,060 
Accounts payable
1,037,107 
671,782 
Customer deposits
149,775 
179,610 
Accrued expenses
639,942 
573,126 
Total current liabilities
3,300,169 
2,836,578 
Other liabilities
92,631 
84,144 
TOTAL LIABILITIES
3,392,800 
2,920,722 
Common stock $0.001 par value, 75,000,000 shares authorized; 49,849,312 and 50,739,312 shares issued and outstanding at June 30, 2014 and March 31, 2014, respectively
49,849 
50,739 
Additional paid-in capital
24,516,030 
24,476,940 
Accumulated deficit
(15,605,489)
(14,597,262)
Treasury stock, 1,000,000 shares at June 30, 2014 and March 31, 2014
(1,000)
(1,000)
Total shareholders' equity
8,959,390 
9,929,417 
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
$ 12,352,190 
$ 12,850,139 
CONDENSED BALANCE SHEETS (Parenthetical) (USD $)
Jun. 30, 2014
Mar. 31, 2014
CONDENSED BALANCE SHEETS
 
 
Common stock, par value (in dollars per share)
$ 0.001 
$ 0.001 
Common stock, shares authorized
75,000,000 
75,000,000 
Common stock, shares issued
49,849,312 
50,739,312 
Common stock, shares outstanding
49,849,312 
50,739,312 
Treasury stock, shares
1,000,000 
1,000,000 
CONDENSED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Revenue
 
 
Product revenue, net
$ 79,338 
$ 258,980 
Licensing revenue
375,000 
 
Revenue, net
454,338 
258,980 
Cost of goods sold
 
 
Cost of goods sold
374,423 
694,110 
Gross margin (deficit)
79,915 
(435,130)
General, administrative, and pre-operating expenses
 
 
Professional and consulting fees
260,235 
514,362 
Salaries and benefits
396,868 
236,837 
Rent, equipment lease and facilities expense
34,147 
37,357 
Marketing costs
10,688 
13,249 
Depreciation and amortization
200,124 
199,874 
Corporate general and administrative
124,153 
101,805 
Total general and administrative expenses
1,026,215 
1,103,484 
Loss from operations
(946,300)
(1,538,614)
Other expense
 
 
Interest expense
(61,927)
(4,582)
Net loss
$ (1,008,227)
$ (1,543,196)
Basic:
 
 
Weighted average number of shares outstanding (in shares)
50,697,993 
48,316,097 
Loss per share (in dollars per share)
$ (0.02)
$ (0.03)
Fully diluted:
 
 
Weighted average number of shares outstanding (in shares)
50,697,993 
48,316,097 
Loss per share (in dollars per share)
$ (0.02)
$ (0.03)
CONDENSED STATEMENTS OF CASH FLOW (USD $)
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities:
 
 
Net loss
$ (1,008,227)
$ (1,543,196)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
Depreciation and amortization
410,322 
372,226 
Expense for warrants, stock and inventory issued in exchange for services
26,200 
211,746 
Employee stock based compensation
 
90,554 
Inventory write down
68,722 
 
Changes in assets and liabilities:
 
 
Decrease in accounts receivable
3,289 
69,042 
Decrease in other receivables
89,192 
 
Decrease/(increase) in prepaid expenses and rent
(4,551)
392 
Decrease/(increase) in inventory and other assets
(101,813)
185,263 
Increase in accounts payable
365,325 
165,535 
Increase/(decrease) in customer deposits
(29,835)
112,272 
Increase/(decrease) in accrued expenses
78,816 
(156,815)
Increase in other liabilities
8,487 
8,487 
Net cash used in operating activities
(94,073)
(484,494)
Cash flows from investing activities:
 
 
Purchase of property, plant and equipment
(13,152)
(15,407)
Net cash used in investing activities
(13,152)
(15,407)
Cash flows from financing activities:
 
 
Proceeds from note payable
61,284 
935,000 
Finance charges paid on note payable
 
(45,000)
Proceeds from sale of common stock - net of fees
 
129 
Net cash provided by financing activities
61,284 
890,129 
Change in cash and cash equivalents
(45,941)
390,228 
Cash and cash equivalents, beginning of period
47,987 
223,257 
Cash and cash equivalents, end of period
2,046 
613,485 
Non-cash investing and financing activities:
 
 
Payment of accrued expenses with STOCK
$ 12,000 
 
CONDENSED STATEMENTS OF SHAREHOLDERS' EQUITY (USD $)
Total
Common Stock
Additional Paid in Capital
Treasury Stock
Accumulated Deficit
Balance at Mar. 31, 2014
$ 9,929,417 
$ 50,739 
$ 24,476,940 
$ (1,000)
$ (14,597,262)
Balance (in shares) at Mar. 31, 2014
50,739,312 
50,739,312 
 
(1,000,000)
 
Increase (Decrease) in Stockholders' Equity
 
 
 
 
 
Common stock issued in exchange for consulting services
26,200 
60 
26,140 
 
 
Common stock issued in exchange for consulting services (in shares)
60,000 
60,000 
 
 
 
Common stock issued in exchange for past consulting services
12,000 
50 
11,950 
 
 
Common stock issued in exchange for past consulting services (in shares)
50,000 
50,000 
 
 
 
Common stock returned to Company and cancelled
 
(1,000)
1,000 
 
 
Common stock returned to Company and cancelled (in shares)
 
(1,000,000)
 
 
 
Net loss for the period
(1,008,227)
 
 
 
(1,008,227)
Balance at Jun. 30, 2014
$ 8,959,390 
$ 49,849 
$ 24,516,030 
$ (1,000)
$ (15,605,489)
Balance (in shares) at Jun. 30, 2014
49,849,312 
49,849,312 
 
(1,000,000)
 
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization and Business

 

Scio Diamond Technology Corporation (referred to herein as the “Company”, “we”, “us” or “our”) was incorporated under the laws of the State of Nevada as Krossbow Holding Corp. on September 17, 2009. The Company’s focus is on man-made diamond technology development and commercialization.

 

Going Concern

 

The Company has generated very little revenue to date and consequently its operations are subject to all risks inherent in the establishment and commercial launch of a new business enterprise.

 

These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management has responded to these circumstances by taking the following actions:

 

·         On-going solicitation of investment in the Company in the form of private placements of common shares, secured and unsecured debt to accredited investors;

·         Focused efforts on new business development opportunities to generate revenues and diversify our customer base;

·         Enhanced efforts on optimizing production for existing manufacturing capabilities; and

·         Continued to explore strategic joint ventures, technology licensing agreements and dedicated contract manufacturing to expand company revenue and cash flow, including our recently agreed to joint venture in China.

 

In the opinion of management, these actions will be sufficient to provide the Company with the liquidity it needs to meet its obligations and continue as a going concern. There can be no assurance, however, that the Company will successfully implement these plans. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

Accounting Basis

 

The accompanying unaudited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations.

 

In the opinion of management, the accompanying unaudited financial statements contain all adjustments (consisting only of normal recurring accruals) necessary to present fairly the Company’s financial position as of June 30, 2014 and March 31, 2014 and the results of operations and cash flows for the three month interim periods ended June 30, 2014 and 2013.  All interim amounts have not been audited, and the results of operations for the interim periods herein are not necessarily indicative of the results of operations to be expected for future periods or the year.  The balance sheet at March 31, 2014 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by GAAP for complete financial statements.  These financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto included in the Form 10-K Annual Report of the Company for the year ended March 31, 2014.

 

In accordance with Accounting Standards Codification (“ASC”) 323, Investments—Equity Method and Joint Ventures, the Company uses the equity method of accounting for investments in corporate joint ventures for which the Company has the ability to exercise significant influence but does not control and is not the primary beneficiary. Significant influence typically exists if the Company has a 20% to 50% ownership interest in the venture unless predominant evidence to the contrary exists. Under this method of accounting, the Company records its proportionate share of the net earnings or losses of equity method investees and a corresponding increase or decrease to the investment balances. Cash payments to equity method investees such as additional investments, loans and advances and expenses incurred on behalf of investees, as well as payments from equity method investees such as dividends, distributions and repayments of loans and advances are recorded as adjustments to investment balances. When the Company’s carrying value in an equity method investee is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the equity method investee or has committed additional funding.   When the equity method investee subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized.  The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may not be recoverable.

 

Basic and Diluted Net Loss per Share

 

Net loss per share is presented under two formats: basic net loss per common share, which is computed using the weighted average number of common shares outstanding during the period, and diluted net loss per common share, which is computed using the weighted average number of common shares outstanding, and the weighted average dilutive potential common shares outstanding, computed using the treasury stock method. Currently, for all periods presented, diluted net loss per share is the same as basic net loss per share as the inclusion of weighted average shares of common stock issuable upon the exercise of options and warrants would be anti-dilutive.

 

The following table summarizes the number of securities outstanding at each of the periods presented, which were not included in the calculation of diluted net loss per share as their inclusion would be anti-dilutive:

 

 

 

June 30,

 

 

 

2014

 

2013

 

Common stock options and warrants

 

8,090,878

 

9,338,045

 

 

Allowance for Doubtful Accounts

 

An allowance for uncollectible accounts receivable is maintained for estimated losses from customers’ failure to make payment on accounts receivable due to the Company. Management determines the estimate of the allowance for uncollectible accounts receivable by considering a number of factors, including: (1) historical experience, (2) aging of accounts receivable and (3) specific information obtained by the Company on the financial condition and the current credit worthiness of its customers.  The Company has determined that an allowance was not necessary at June 30, 2014 or March 31, 2014.

 

Other Receivables

 

As of March 31, 2014, the Company considered a pending insurance settlement over the actions of a Company supplier of $89,192 as an other receivable.  This settlement was paid during the three months ended June 30, 2014.

 

Inventories

 

Inventories are stated at the lower of average cost or market. The carrying value of inventory is reviewed and adjusted based upon slow moving and obsolete items. Inventory costs include material, labor, and manufacturing overhead and are determined by the “first-in, first-out” (FIFO) method.  The components of inventories are as follows:

 

 

 

June 30,
2014

 

March 31,
2014

 

Raw materials and supplies

 

$

28,702

 

$

35,543

 

Work in process

 

44,708

 

25,611

 

Finished goods

 

112,498

 

91,663

 

 

 

$

185,908

 

$

152,817

 

 

During the three months ended June 30, 2014, we continued to experience selling prices lower then cost. As a result during the three months ended June 30, 2014, we recorded a lower of cost or market write down of $68,723 for inventory produced during the three months ended June 30, 2014 that was still on hand at June 30, 2014.  The estimation of the total write-down involves management judgments and assumptions including assumptions regarding future selling price forecasts, the estimated costs to complete, disposal costs and a normal profit margin.

 

Property, Plant and Equipment

 

Depreciation of property, plant and equipment is on a straight line basis beginning at the time it is placed in service, based on the following estimated useful lives:

 

 

 

Years

 

Machinery and equipment

 

3—15

 

Furniture and fixtures

 

3—10

 

Engineering equipment

 

5—12

 

 

Leasehold improvements are depreciated over the lesser of the remaining term of the lease or the life of the asset (generally three to seven years).

 

Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred.

 

Intangible Assets

 

Intangible assets, such as acquired in-process research and development costs, are considered to have an indefinite useful life until such time as they are put into service at which time they will be amortized on a straight-line basis over the shorter of their economic or legal useful life. Management evaluates indefinite life intangible assets for impairment on an annual basis and on an interim basis if events or changes in circumstances between annual impairment tests indicate that the asset might be impaired. The ongoing evaluation for impairment of its indefinite life intangible assets requires significant management estimates and judgment.  Management reviews definite life intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. There were no impairment charges during the three months ended June 30, 2014 or 2013.

 

Fair Value Measurement

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy prescribed by the accounting literature contains three levels as follows:

 

Level 1— Quoted prices in active markets for identical assets or liabilities.

 

Level 2— Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3— Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.

 

The carrying value of cash and cash equivalents, accounts receivable, other assets and trade accounts payable approximates fair value due to the short-term nature of these instruments.

 

Revenue Recognition

 

We recognize product revenue when persuasive evidence of an arrangement exists, delivery of products has occurred, the sales price is fixed or determinable, and collectability is reasonably assured. For our Company, this generally means that we recognize revenue when we or our fabrication vendor has shipped finished product to the customer. Our sales terms do not allow for a right of return except for matters related to any manufacturing defects on our part.  The Company recognizes licensing and development revenues in accordance with the contractual terms of the agreements.

 

Recent Accounting Pronouncements

 

In July 2013, the FASB issued ASC 2013-11, “Income Taxes — Presentation of an Unrecognized Tax benefit When a Net Operation Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”  (“ASU 2013-11”) which is part of Accounting Standards Codification (“ASC”) 740: Income Taxes.  The new guidance requires and entity to present an unrecognized tax benefit and an NOL carryforward, a similar tax loss or a tax credit carryforward on a net basis as part of a deferred tax asset, unless the unrecognized tax benefit is not available to reduce the deferred tax asset component or would not be utilized for that purpose, then a liability would be recognized.  ASU 2013-11 is effective for annual and interim periods for fiscal years beginning after December 15, 2013.  The Company adopted this new standard for the fiscal year ended March 31, 2015 and the adoption has not had a significant impact on its financial statements.

 

In May 2014, the FASB issued ASU 2014-9 “Revenue from Contracts with Customers (Topic 606).” This guidance requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance is effective for annual reporting periods beginning after December 15, 2016 and early adoption is not permitted. The Company will adopt this standard in fiscal year 2018. The Company has not yet determined the effect, if any, that the adoption of this standard will have on the Company’s financial position or results of operation.

 

There are currently no other accounting standards that have been issued but not yet adopted by the Company that will have a significant impact on the Company’s financial position, results of operations or cash flows upon adoption.

INTANGIBLE ASSETS
INTANGIBLE ASSETS

NOTE 2 — INTANGIBLE ASSETS

 

Intangible assets, such as acquired in-process research and development costs, are considered to have an indefinite useful life until such time as they are put into service at which time they will be amortized on a straight-line basis over the shorter of their economic or legal useful life.

 

Intangible assets consist of the following:

 

 

 

 

 

June 30,

 

March 31,

 

 

 

Life

 

2014

 

2014

 

Patents, gross

 

6.75 – 19.46

 

$

8,135,063

 

$

8,135,063

 

In-process research and development

 

Indefinite

 

2,250,435

 

2,250,435

 

 

 

 

 

10,385,498

 

10,385,498

 

Accumulated amortization

 

 

 

1,338,359

 

1,144,858

 

Net intangible assets

 

 

 

$

9,047,139

 

$

9,240,640

 

 

Total amortization expense for the quarter ending June 30, 2014 and 2013 was $193,710 and $193,753, respectively.

 

Total annual amortization expense of finite lived intangible assets is estimated to be as follows:

 

Fiscal Year Ending

 

 

 

Nine months ending March 31, 2015

 

$

581,301

 

March 31, 2016

 

775,011

 

March 31, 2017

 

775,011

 

March 31, 2018

 

775,011

 

March 31, 2019

 

775,011

 

Thereafter

 

$

3,115,359

 

 

NOTES PAYABLE
NOTES PAYABLE

NOTE 3 — NOTES PAYABLE

 

During the quarter ended June 30, 2013, the Company entered into a loan agreement with Platinum Capital Partners, LP (“Platinum”) providing for a $1 million secured revolving line of credit that the Company may draw on to fund working capital and other corporate purposes.  At June 30, 2013, the Company had utilized a portion of these funds to fund its ongoing operations.  Borrowings under the loan agreement accrue interest at the rate of 18% per annum, payable monthly on or before the last calendar day of each month, and a service charge of 3% applies to late payments.  The loan agreement also provides for payment of an accommodation fee of up to 10% of the commitment amount as provided in the loan agreement, and payment of a monthly collateral monitoring fee of $2,000 per month for the first six months and $1,000 per month for the last six months of the term of the loan agreement.  The loan agreement contains a number of restrictions on the Company’s business, including restrictions on its ability to merge, sell assets, create or incur liens on assets, make distributions to its shareholders and sell, purchase or lease real or personal property or other assets or equipment.  The loan agreement also contains affirmative covenants and events of default.  The Company may prepay borrowings without premium or penalty upon notice to Platinum as provided in the loan agreement.  Under a security agreement entered into in connection with the loan agreement, the Company granted Platinum a first priority security interest in the Company’s inventory, equipment, accounts and other rights to payments and intangibles as security for the loan.

 

On October 11, 2013, the Company entered into a First Amendment to Loan Agreement (the “First Amendment”), with Platinum, which amends the Original Loan Agreement (as amended by the First Amendment, the “Amended Loan Agreement”) to provide for an additional $500,000 of borrowing capacity (the “Additional Loan” and, together with the original Loan, the “Loan”) under the existing $1 million secured revolving line of credit established under the Original Loan Agreement.  The Company may draw on the line to fund working capital.  On October 11, 2013, $280,750 was drawn on the Additional Loan, $30,750 of which was retained by Platinum to cover applicable fees.

 

Borrowings accrue interest at the rate of 18% per annum, payable monthly on or before the last calendar day of each month. An interest reserve of $133,500 has been set aside from the proceeds of the New Note to make required payments of interest, provided that interest billed to the Company will first be deducted from a $90,000 reserve established under the Original Note for payments of interest on the Original Note, until that reserve has been exhausted. The Amended Loan Agreement also provides for payment of an accommodation fee of $25,000 and a closing fee of $3,250, the amounts of which were retained by Platinum out of amounts drawn on the Additional Loan on October 11, 2013.  The Company’s obligations under the Amended Loan Agreement are not guaranteed by any other party.  The Company may prepay borrowings without premium or penalty upon notice to Platinum as provided in the Amended Loan Agreement.  The Loan is secured by a security agreement, under which the Company grants Platinum first priority security interest in the Company’s inventory, equipment, accounts and other rights to payments and intangibles as security for the Loan.  The New Note provides for monthly interest payments commencing November 2013 and for repayment of all amounts drawn, together with accrued interest, on June 20, 2014.

 

The Company has utilized funds drawn on the Original Loan and the Additional Loan to fund its ongoing operations.  The Company has capitalized financing costs related to the Platinum loans of $150,750 that are being amortized over the life of the loans.  At June 30, 2014, the total due Platinum including all accrued fees was $1,473,345.

 

The Platinum loans matured on June 20, 2014 and the Company went into default status on the loans.  In default status, Platinum could foreclose on the loan and has the right to take possession of the collateral including the Company’s fixed assets and intellectual property.   In addition, in default status, Platinum has the right to increase the interest rate on the note by 3% upon 30 day notice to the Company.  To date, Platinum has not taken any action related to this default, including adjusting the interest rate, as the Company continues to pursue additional financing alternatives.

CAPITAL STOCK
CAPITAL STOCK

NOTE 4 — CAPITAL STOCK

 

The authorized capital of the Company is 75,000,000 common shares with a par value of $ 0.001 per share.

 

At the request of the Board of Directors, the Company’s entered into an agreement, effective April 12, 2014, with Mr. Joseph Cunningham to provide consulting services to the Company.  Under this agreement, the Company agreed to provide Mr. Cunningham $4,000 and 20,000 shares of common stock per month in exchange for his professional services to the Company.  Through June 30, 2014, the Company had issued 60,000 shares to Mr. Cunningham.  These shares were valued at an average of $0.44 per share based on the closing price of the shares on the date of grant and the Company recognized $26,200 in professional and consulting fee expense for these shares, during the three months ended June 30, 2014.

 

On April 15, 2014, the Company entered into a Rights Agreement between the Company and Empire Stock Transfer Inc., as Rights Agent (as amended from time to time, the “Rights Agreement”) that was previously approved by the Board of Directors of the Company.

 

In connection with the Rights Agreement, a dividend was declared of one common stock purchase right (individually, a “Right” and collectively, the “Rights”) for each share of common stock, par value $0.001 per share (the “Common Stock”), of the Company outstanding at the close of business on April 25, 2014 (the “Record Date”).  Each Right will entitle the registered holder thereof, after the Rights become exercisable and until April 15, 2017 (or the earlier redemption, exchange or termination of the Rights), to purchase from the Company one share of Common Stock of the Company at a price of $1.20 per share of Common Stock (the “Purchase Price”).  Until the earlier to occur of (i) the close of business on the tenth business day following a public announcement that a person or group of affiliated or associated persons has acquired, or obtained the right to acquire, beneficial ownership of 17% or more of the Common Stock (an “Acquiring Person”) or (ii) the close of business on the tenth business day (or such later date as may be determined by action of the Board of Directors prior to such time as any person or group of affiliated or associated persons becomes an Acquiring Person) following the commencement or announcement of an intention to make a tender offer or exchange offer the consummation of which would result in the beneficial ownership by a person or group of affiliated or associated persons of 17% or more of the Common Stock (the earlier of (i) and (ii) being called the “Distribution Date”), the Rights will be evidenced, with respect to any of the Common Stock certificates outstanding as of the Record Date, by such Common Stock certificates, or, with respect to any uncertificated Common Stock registered in book entry form, by notation in book entry, in either case together with a copy of the Summary of Rights attached as Exhibit B to the Rights Agreement.  Under the Rights Agreement, synthetic ownership of Common Stock in the form of derivative securities counts towards the 17% ownership threshold, to the extent actual shares of Common Stock equivalent to the economic exposure created by the derivative security are directly or indirectly beneficially owned by a counterparty to such derivative security.

 

The Rights Agreement provided that any person who beneficially owned 17% or more of the Common Stock immediately prior to the first public announcement of the adoption of the Rights Agreement, together with any affiliates and associates of that person (each an “Existing Holder”), shall not be deemed to be an “Acquiring Person” for purposes of the Rights Agreement unless an Existing Holder becomes the beneficial owner of one or more additional shares of Common Stock (other than pursuant to a dividend or distribution paid or made by the Company on the outstanding Common Stock in Common Stock or pursuant to a split or subdivision of the outstanding Common Stock).  However, if upon acquiring beneficial ownership of one or more additional shares of Common Stock, the Existing Holder does not beneficially own 17% or more of the Common Stock then outstanding, the Existing Holder shall not be deemed to be an “Acquiring Person” for purposes of the Rights Agreement.

 

On June 22, 2014, the Board of Directors amended the Rights Agreement to accelerate the expiration date and effectively terminated all rights granted under the agreement.  Since none of the rights were exercised prior to expiration, there was no financial impact of the rights offering.

 

On June 20, 2014, the Board of Directors granted restricted stock grants to Mr. Michael Laub of 50,000 shares for previously performed services rendered to the Company.  The Company does not anticipate recognizing any expense for this restricted stock grants since it was in exchange for expenses previously accrued by the Company.

 

On June 23, 2014, the Company entered into a settlement agreement (see Item 1, Note 8 — LITIGATION below for more details) whereby amongst other things, Messrs. Edward Adams and Michael Monahan forfeited 1,000,000 shares of stock to the Company.  These shares were subsequently cancelled as of this date.

 

The Company had 49,849,312 shares of common stock issued and outstanding as of June 30, 2014 of which 1,000,000 were held in treasury.

 

The Company had 5,566,795 warrants outstanding with a weighted average exercise price of $1.53 per share as of June 30, 2014.  No warrants were issued in the three months ended June 30, 2014.

SHARE-BASED COMPENSATION
SHARE-BASED COMPENSATION

NOTE 5 — SHARE-BASED COMPENSATION

 

The Company currently has one equity-based compensation plan under which stock-based compensation awards can be granted to directors, officers, employees and consultants providing bona fide services to or for the Company.   The Company’s 2012 Share Incentive Plan was adopted on May 7, 2012 (the “2012 Share Incentive Plan” or “Plan”) and allows the Company to issue up to 5,000,000 shares of its common stock pursuant to awards granted under the 2012 Share Incentive Plan.  The Plan permits the granting of stock options, stock appreciation rights, restricted or unrestricted stock awards, phantom stock, performance awards, other stock-based awards, or any combination of the foregoing.  The only awards that have been issued under the Plan are stock options.   Because the Plan has not been approved by our shareholders, all such stock option awards are non-qualified stock options.  The following sets forth the options to purchase shares of the Company’s stock issued and outstanding as of June 30, 2014:

 

Options

 

Shares

 

Weighted-
Average Exercise
Price

 

Weighted-Average
Remaining
Contractual Term

 

Options Outstanding March 31, 2014

 

4,342,500

 

$

0.77

 

1.75

 

Granted

 

 

 

 

Exercised

 

 

 

 

Expired/cancelled

 

(1,818,417

)

0.87

 

 

Options Outstanding June 30, 2014

 

2,524,083

 

$

0.69

 

1.49

 

Exercisable at June 30, 2014

 

2,049,708

 

$

0.77

 

1.35

 

 

A summary of the status of non-vested shares as of June 30, 2014 and changes during the three month ended June 30, 2014 is presented below.

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Grant-Date

 

Non-vested Shares

 

Shares

 

Fair Value

 

Non-vested at March 31, 2014

 

2,414,792

 

0.49

 

Granted

 

 

 

 

Vested

 

(122,000

)

0.43

 

Expired/cancelled: non-vested

 

(1,818,417

)

0.56

 

Non-vested at June 30, 2015

 

474,375

 

$

0.23

 

 

The following table summarizes information about stock options outstanding by price range as of June 30, 2014:

 

 

 

Options Outstanding

 

Options Exercisable

 

Range of
Exercise Price

 

Number
Outstanding

 

Weighted Average
Remaining
Contractual Life
(years)

 

Weighted Average
Exercise Price

 

Number of
Shares

 

Weighted Average
Exercise Price

 

$0.83 - $1.02

 

885,333

 

1.61

 

$

0.92

 

885,333

 

$

0.92

 

$0.70 - $0.80

 

982,500

 

1.17

 

0.71

 

940,500

 

0.71

 

$0.33 - $0.42

 

656,250

 

2.24

 

0.36

 

223,875

 

0.41

 

 

 

2,524,083

 

1.49

 

$

0.69

 

2,049,708

 

$

0.77

 

 

The Company initially issued options with exercise prices of $0.70 or $0.80 per share which were the prices of recent equity capital investment.  However, in December 2012, the Company decided to change the exercise price policy by utilizing the stock market closing price on the day that the options were granted by our Board of Directors.  All subsequent exercise prices have been determined in this manner.

 

The intrinsic value of options outstanding at June 30, 2014 and March 31, 2014 was $0 and $0, respectively.

 

The Company estimates the fair value of options granted on the grant date utilizing the Black-Scholes Option Pricing model.  For the three months ended June 30, 2014 and 2013, the Company recognized $0 and $90,554, respectively, as compensation cost for options issued, and recorded related deferred tax asset of $0 for all periods.

 

At June 30, 2014, unrecognized compensation cost related to non-vested awards was $108,979.  This cost is expected to be recognized over a weighted average period of 2.11 years.  The total fair value of options vested during the three months ended June 30, 2014 and 2013 was $52,580 and $0, respectively.

RELATED PARTIES
RELATED PARTIES

NOTE 6 — RELATED PARTIES

 

On May 27, 2014, the Board of Directors appointed Mr. James Korn and Mr. Gerald McGuire as independent members to the Board.  Each of Messrs. Korn and McGuire were provided 250,000 shares of restricted stock upon their appointment to the Board.

 

On June 12, 2014, the Board of Directors decided to terminate without cause the employment of Chief Executive Officer, Michael McMahon and Chief Financial Officer, Jonathan Pfohl.  The Board named then Board Member Gerald McGuire as interim Chief Executive Officer and appointed Mr. Douglas Walker as interim Chief Financial Officer.  The Board also named Mr. Michael Laub as Chief Restructuring Officer.

 

On June 16, 2014, the Board of Directors appointed Bruce Likly as a member of Board and further appointed Mr. Likly to serve as the Co-Chairman of the Board.  Mr. Likly was provided with a restricted share grant of 4,000,000 shares upon his appointment to the Board.

 

On June 20, 2014, the Board of Directors granted restricted stock grants to Mr. Michael Laub of 50,000 shares in exchange for $12,000 of liabilities owed to Mr. Laub for professional services provided to the Company.  These shares were valued at $0.24 per share based on the liabilities owed to Mr. Laub.  The Company does not anticipate recognizing any expense for this restricted stock grants since it was in exchange for expenses previously accrued by the Company.

 

On June 22, 2014, the equity granted to Messrs. Korn, Likly, and McGuire for their service on the Board of Directors consisting of 250,000, 4,000,000 and 250,000 restricted shares, respectively was returned to the Company.  In addition, all equity granted and contemplated to be granted to Messrs. McGuire, Walker and Laub for their services as executive officers of the Company was effectively returned to the Company.  The Company did not recognize any expense for the restricted shares granted and returned to the Company since none of the grants had vested at the time of their return to the Company.

 

On June 25, 2014, Jonathan Pfohl returned to the Company as Acting Chief Financial Officer.

INVESTMENT IN JOINT VENTURE
INVESTMENT IN JOINT VENTURE

NOTE 7 — INVESTMENT IN JOINT VENTURE

 

On September 16, 2013, the Company entered into a series of agreements with SAAMABA, LLC (“SAAMABA”) and S21 Research Holdings (the “Grace Rich Agreements”) to form a joint venture with operations in the People’s Republic of China (“PRC”) to deploy a minimum of 100 Company designed diamond growing machines.  Through the Grace Rich Agreements, the Company owns 30% of Grace Rich LTD, a corporation duly established pursuant to the laws of the Hong Kong Special Administrative Region of the PRC that is an investment and holding company for the factory and distribution center to be formed pursuant to the laws of the PRC as a wholly foreign owned enterprise.

 

Under the Grace Rich Agreements, the Company has agreed to license its proprietary technology for the manufacture of diamond gemstones of agreed upon specifications.  In exchange for the license, the Company will receive licensing revenue and 30% ownership in the joint venture.  In addition to the licensed technology, the Grace Rich Agreements include obligations for the Company to provide and be compensated for technology consulting services to the joint venture to support the start-up of operations.

 

The initial ownership interests in Grace Rich Limited are as follows:  SAAMABA LLC- 60%; Scio Diamond Technology Corporation — 30% and S21 Holdings- 10%.  The capital contributions required to finance Grace Rich LTD are requirements of SAAMABA, and the Company is not required to make any on-going funding contributions to the joint venture and its ownership stake cannot be reduced from 30%.

 

The Company is licensing a portion of its patented technology to Grace Rich LTD and is not directly contributing any of its intellectual property.  The license agreement calls for the Company to receive $250,000 in licensing fees and $750,000 in development fees between October 2013 and June 2014.  As of June 30, 2014, the Company has received these payments.  In addition, once operations of Grace Rich LTD have commenced, the Company will receive $250 per machine per month in licensing fees with a minimum payment of $25,000 until the venture starts to distribute cash to its partners.

 

The Company determined the fair value of the license agreement does not exceed the value of the expected returns from the joint venture and accordingly has established an initial investment value of $0 and has not recorded any gains related to its contribution to the joint venture.  The Company joint venture was in its development stage through June 30, 2014 and did not have any revenues.  Expenses incurred by the joint venture were for planning and startup expenses.  The total loss of the joint venture from during the three months ended June 30, 2014 was $680,141. The Company’s corresponding 30% share of these losses was $204,042.

 

As of June 30, 2014, the Company has not guaranteed obligations of the joint venture nor has it committed to pride additional funding. Therefore, the Company’s share of the joint venture’s net loss through June 30, 2014 was not recognized because the initial carrying value of the Company’s ownership interest in the joint venture was zero.

 

Rollforward of the Company’s ownership interest in the joint venture for the three months ended June 30, 2014:

 

Balance of ownership interest in joint venture at March 31, 2014

 

$

(313,184

)

Aggregate 2015 equity loss — share of joint venture losses

 

(204,042

)

2015 equity loss — share of joint venture losses not recognized due to basis limitation

 

204,042

 

Balance of ownership interest in joint venture at June 30, 2014

 

$

 

 

 

 

 

Cumulative unrecognized loss on ownership interest in joint venture at June 30, 2014

 

$

(517,226

)

 

Selected financial results for Grace Rich LTD for three months ended June 30, 2014 are as follows:

 

Revenues

 

$

 

Expenses

 

680,141

 

Net Income (Loss)

 

$

(680,141

)

 

 

 

 

Total Assets

 

$

69,597

 

 

 

 

 

Total Liabilities

 

$

1,792,382

 

Total Partners Capital

 

(1,722,786

)

Total Liabilities and Partner Capital

 

$

69,597

 

 

The Company recognized $375,000 in revenues from Grace Rich during the three months ended June 30, 2014. The Company incurred $72,555 of joint venture related expenses during the three months ended June 30, 2014 that are reimbursable by Grace Rich LTD.  These anticipated reimbursements were offset against the Company’s related operating expense.

LITIGATION
LITIGATION

NOTE 8 — LITIGATION

 

On July 26, 2013, Bernard M. McPheely, Trustee for the Bernard M. McPheely Revocable Trust Dated May 25, 2012, Thomas P. Hartness, Trustee for the Thomas P. Hartness Revocable Trust Dated July 31, 2010, Brian McPheely and Robert Daisley (collectively, “Plaintiffs”), derivatively and on behalf of the Company, filed a complaint in the Court of Common Pleas of the State of South Carolina, County of Greenville against Edward S. Adams (then our Chairman), Michael R. Monahan (a former member of the Company’s Board of Directors), Robert Linares (a then current member of the Board), Theodorus Strous (a then current member of the Board) and the law firm of Adams Monahan, LLP (collectively, “Defendants”), and the Company, as a nominal defendant (the “Scio Derivative Complaint”).  Bernard M. McPheely is a former member of the Company’s Board of Directors.

 

The Scio Derivative Complaint alleged (i) against Defendants, breach of fiduciary duty, corporate waste and unjust enrichment; (ii) against Messrs. Strous and Linares and Adams Monahan LLP, aiding and abetting a breach of fiduciary duty; (iii) against Messrs. Adams and Monahan, civil conspiracy; (iv) against Messrs. Adams, Monahan and Linares, breach of fiduciary duty — controlling shareholder; and (v) against Mr. Strous and Adams Monahan LLP, aiding and abetting a breach of controlling shareholder duty.  The allegations relate to, among other things, certain actions allegedly taken by defendants in connection with: the acquisition by the Company of certain assets of ADI (the “ADI Asset Purchase”); the ADGC Asset Purchase; the Company’s agreement to provide certain current and former stockholders of ADI and ADGC the opportunity to acquire up to approximately 16 million and 1 million shares, respectively, of common stock of the Company for $0.01 per share (collectively, the “ADI/ADGC Offering”); the provision of legal services by Adams Monahan LLP to the Company; certain equity issuances by the Company following the ADI/ADGC Offering; certain bonuses and other payments paid to members of the Board of Directors; and certain indemnification obligations undertaken by the Company in favor of Messrs. Adams and Monahan.

 

Plaintiffs were seeking direct and consequential damages sustained by the Company in an amount to be established through proof at trial, plus pre-judgment and post-judgment interest; appropriate equitable relief to remedy the alleged breaches of fiduciary duties; reasonable attorney’s fees and costs for the Company incurred in prosecuting the action; and other relief as deemed by the court to be just and proper.

 

Defendants removed the Scio Derivative Complaint to the U.S. District Court for the District of South Carolina, Greenville Division (the “Federal Court”) and filed a motion to dismiss the complaint on October 4, 2013.  On December 16, 2013, the Federal Court granted the Defendants’ motion to dismiss, in part based on the plaintiffs’ lack of standing, and the remaining claims were dismissed by the court without prejudice in favor of mandatory arbitration proceedings

 

On October 15, 2013, plaintiff Mark P. Sennott, as Trustee of the Sennott Family Charitable Trust, (“Sennott”) filed a complaint derivatively, on behalf of ADI, in the Federal Court, against Edward S. Adams (our then Chairman), Michael R. Monahan (a former member of the Company’s Board of Directors), the law firm of Adams Monahan, LLP, Loblolly, Inc., which was formerly known as Scio Diamond Technology Corporation, and the Company (collectively, “Sennott Defendants”).  This derivative complaint on ADI’s behalf (the “ADI Derivative Complaint”) alleges claims for breach of fiduciary duty, constructive fraud and unjust enrichment.  The allegations in the ADI Derivative Complaint are duplicative of the Scio Derivative Complaint allegations concerning ADI, which were dismissed by the Federal Court’s December 16, 2013 order in the Scio Derivative Complaint and repeat almost verbatim the allegations from earlier lawsuits filed and dismissed in 2012 against the Defendants, which were previously disclosed in the Company’s Form 10-Q for the nine months ended December 31, 2012 and Form 10-K for fiscal year ended March 31, 2013.  Sennott is seeking direct and consequential damages sustained by Sennott in an amount to be established through proof at trial, plus pre-judgment and post-judgment interest; appropriate equitable relief to remedy the allegedly wrongful acts; reasonable attorney’s fees and costs incurred in prosecuting the action; and other relief as deemed by the court to be just and proper.

 

Both the Scio Derivative Complaint and the ADI Derivative Complaint were effectively settled on June 23, 2014 when the Company entered into a settlement agreement (the “Settlement Agreement”) by and among Edward S. Adams, Michael R. Monahan, Gerald McGuire, James Korn, Bruce Likly, Theodorus Strous, and Robert C. Linares, their present and past affiliates, such as Apollo Diamond, Inc., Apollo Diamond Gemstone Corporation, Adams Monahan LLP, Focus Capital Group, Inc. and Oak Ridge Financial Services Group, Inc., family members and spouses (the “Adams Group”), and Thomas P. Hartness, Kristoffer Mack, Paul Rapello, Glen R. Bailey, Marsha C. Bailey, Kenneth L. Smith, Bernard M. McPheely, James Carroll, Robert M. Daisley, Ben Wolkowitz, Craig Brown, Ronnie Kobrovsky, Lewis Smoak, Brian McPheely, Mark P. Sennott, the Sennott Family Charitable Trust, and their affiliates (the “Save Scio Group”),  pursuant to which the Company and the Save Scio Group settled the previously pending consent contest for the election of directors. Pursuant to the Settlement Agreement, on June 23, 2014, Messrs. Adams, Strous, Linares and McGuire resigned as directors effective immediately; the Board expanded the size of the Board to 7 directors and appointed Messrs. McPheely, Wolkowitz, Smoak and Leaverton (the “Save Scio Nominees”) to fill all but one of the resulting vacancies. In addition, the Company agreed to nominate each of Messrs. Korn and Likly (the “Adams Group Nominees”) and the Save Scio Nominees for election to the Board at the Company’s 2014 annual meeting of stockholders. Pursuant to the Settlement Agreement, the Adams Group and the Save Scio Group must vote their shares of Common Stock for the other’s nominees for the next three years, and will also have replacement rights in the event these nominees are unable to serve as directors.

 

The Settlement Agreement contains various other terms and provisions, including with respect to the transfer of one million shares of Common Stock from the Adams Group to the Save Scio Group, a portion of which is allocated for reimbursement of the Save Scio Group’s out-of-pocket expenses in connection with the nomination of the Save Scio Nominees and past litigation involving certain members of the Adams Group and the Save Scio Group (the Scio Derivative Complaint and the ADI Derivative Complaint collectively known as the “Litigation”), the Save Scio Group’s withdrawal of the Litigation, termination of the Save Scio Group’s consent solicitation, and accelerated expiration of the Company’s stockholder Rights Agreement adopted on April 15, 2014. Also included in the settlement is the forfeiture of one million shares of common stock by Edward S. Adams and Michael Monahan for cancellation by Scio.

 

Concurrent with the Settlement Agreement, the equity granted to Messrs. Korn, Likly, and McGuire for their service on the Board of Directors consisting of 250,000, 4,000,000 and 250,000 restricted shares, respectively was returned to the Company.   In addition, all equity granted and contemplated to be granted to Messrs. McGuire, Walker and Laub for their services as executive officers of the Company was effectively returned to the Company.  The Company did not recognize any expense for the restricted shares granted and returned to the Company since none of the grants had vested at the time of their return to the Company.

 

In addition, the Settlement agreement provides for the release of all liabilities amongst the parties.  This release resulted in the reversal of $343,556 of consulting and professional fees due to the settling parties for board fees, management committee fees, consulting services, indemnification of board members and legal expenses that were previously recorded as professional and consulting fees.  $232,806 of these consulting and professional fees were accrued as of March 31, 2014.

 

On May 16, 2014 the Company received a subpoena issued by the SEC ordering the provision of documents and related information concerning various corporate transactions between the Company and its predecessors and other persons and entities.  The Company is fully cooperating with this inquiry.

SUBSEQUENT EVENTS
SUBSEQUENT EVENTS

NOTE 9 — SUBSEQUENT EVENTS

 

On July 11, 2014, the Board of Directors named Mr. Gerald McGuire, President, Chief Executive Officer and Director of the of the Company.  As of the date of this filing, the Company has not entered into an employment contract with Mr. McGuire.

 

On July 15, 2014, the Board of Directors approved the issuance and sale of up to 2,000,000 shares of common stock to accredited investors at a price of $0.30.  The Company may raise up to $600,000 from this offering and does not anticipate incurring any material expenses related to the offering.  Through August 8, 2014, the Company has issued 750,000 shares under this offering and raised $225,000.

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

Going Concern

 

The Company has generated very little revenue to date and consequently its operations are subject to all risks inherent in the establishment and commercial launch of a new business enterprise.

 

These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management has responded to these circumstances by taking the following actions:

 

·         On-going solicitation of investment in the Company in the form of private placements of common shares, secured and unsecured debt to accredited investors;

·         Focused efforts on new business development opportunities to generate revenues and diversify our customer base;

·         Enhanced efforts on optimizing production for existing manufacturing capabilities; and

·         Continued to explore strategic joint ventures, technology licensing agreements and dedicated contract manufacturing to expand company revenue and cash flow, including our recently agreed to joint venture in China.

 

In the opinion of management, these actions will be sufficient to provide the Company with the liquidity it needs to meet its obligations and continue as a going concern. There can be no assurance, however, that the Company will successfully implement these plans. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Accounting Basis

 

The accompanying unaudited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations.

 

In the opinion of management, the accompanying unaudited financial statements contain all adjustments (consisting only of normal recurring accruals) necessary to present fairly the Company’s financial position as of June 30, 2014 and March 31, 2014 and the results of operations and cash flows for the three month interim periods ended June 30, 2014 and 2013.  All interim amounts have not been audited, and the results of operations for the interim periods herein are not necessarily indicative of the results of operations to be expected for future periods or the year.  The balance sheet at March 31, 2014 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by GAAP for complete financial statements.  These financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto included in the Form 10-K Annual Report of the Company for the year ended March 31, 2014.

 

In accordance with Accounting Standards Codification (“ASC”) 323, Investments—Equity Method and Joint Ventures, the Company uses the equity method of accounting for investments in corporate joint ventures for which the Company has the ability to exercise significant influence but does not control and is not the primary beneficiary. Significant influence typically exists if the Company has a 20% to 50% ownership interest in the venture unless predominant evidence to the contrary exists. Under this method of accounting, the Company records its proportionate share of the net earnings or losses of equity method investees and a corresponding increase or decrease to the investment balances. Cash payments to equity method investees such as additional investments, loans and advances and expenses incurred on behalf of investees, as well as payments from equity method investees such as dividends, distributions and repayments of loans and advances are recorded as adjustments to investment balances. When the Company’s carrying value in an equity method investee is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the equity method investee or has committed additional funding.   When the equity method investee subsequently reports income, the Company will not record its share of such income until it equals the amount of its share of losses not previously recognized.  The Company evaluates its equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may not be recoverable.

Basic and Diluted Net Loss per Share

 

Net loss per share is presented under two formats: basic net loss per common share, which is computed using the weighted average number of common shares outstanding during the period, and diluted net loss per common share, which is computed using the weighted average number of common shares outstanding, and the weighted average dilutive potential common shares outstanding, computed using the treasury stock method. Currently, for all periods presented, diluted net loss per share is the same as basic net loss per share as the inclusion of weighted average shares of common stock issuable upon the exercise of options and warrants would be anti-dilutive.

 

The following table summarizes the number of securities outstanding at each of the periods presented, which were not included in the calculation of diluted net loss per share as their inclusion would be anti-dilutive:

 

 

 

June 30,

 

 

 

2014

 

2013

 

Common stock options and warrants

 

8,090,878

 

9,338,045

 

 

Allowance for Doubtful Accounts

 

An allowance for uncollectible accounts receivable is maintained for estimated losses from customers’ failure to make payment on accounts receivable due to the Company. Management determines the estimate of the allowance for uncollectible accounts receivable by considering a number of factors, including: (1) historical experience, (2) aging of accounts receivable and (3) specific information obtained by the Company on the financial condition and the current credit worthiness of its customers.  The Company has determined that an allowance was not necessary at June 30, 2014 or March 31, 2014.

Other Receivables

 

As of March 31, 2014, the Company considered a pending insurance settlement over the actions of a Company supplier of $89,192 as an other receivable.  This settlement was paid during the three months ended June 30, 2014.

Inventories

 

Inventories are stated at the lower of average cost or market. The carrying value of inventory is reviewed and adjusted based upon slow moving and obsolete items. Inventory costs include material, labor, and manufacturing overhead and are determined by the “first-in, first-out” (FIFO) method.  The components of inventories are as follows:

 

 

 

June 30,
2014

 

March 31,
2014

 

Raw materials and supplies

 

$

28,702

 

$

35,543

 

Work in process

 

44,708

 

25,611

 

Finished goods

 

112,498

 

91,663

 

 

 

$

185,908

 

$

152,817

 

 

During the three months ended June 30, 2014, we continued to experience selling prices lower then cost. As a result during the three months ended June 30, 2014, we recorded a lower of cost or market write down of $68,723 for inventory produced during the three months ended June 30, 2014 that was still on hand at June 30, 2014.  The estimation of the total write-down involves management judgments and assumptions including assumptions regarding future selling price forecasts, the estimated costs to complete, disposal costs and a normal profit margin.

Property, Plant and Equipment

 

Depreciation of property, plant and equipment is on a straight line basis beginning at the time it is placed in service, based on the following estimated useful lives:

 

 

 

Years

 

Machinery and equipment

 

3—15

 

Furniture and fixtures

 

3—10

 

Engineering equipment

 

5—12

 

 

Leasehold improvements are depreciated over the lesser of the remaining term of the lease or the life of the asset (generally three to seven years).

 

Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred.

Intangible Assets

 

Intangible assets, such as acquired in-process research and development costs, are considered to have an indefinite useful life until such time as they are put into service at which time they will be amortized on a straight-line basis over the shorter of their economic or legal useful life. Management evaluates indefinite life intangible assets for impairment on an annual basis and on an interim basis if events or changes in circumstances between annual impairment tests indicate that the asset might be impaired. The ongoing evaluation for impairment of its indefinite life intangible assets requires significant management estimates and judgment.  Management reviews definite life intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. There were no impairment charges during the three months ended June 30, 2014 or 2013.

Fair Value Measurement

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy prescribed by the accounting literature contains three levels as follows:

 

Level 1— Quoted prices in active markets for identical assets or liabilities.

 

Level 2— Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3— Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.

 

The carrying value of cash and cash equivalents, accounts receivable, other assets and trade accounts payable approximates fair value due to the short-term nature of these instruments.

Revenue Recognition

 

We recognize product revenue when persuasive evidence of an arrangement exists, delivery of products has occurred, the sales price is fixed or determinable, and collectability is reasonably assured. For our Company, this generally means that we recognize revenue when we or our fabrication vendor has shipped finished product to the customer. Our sales terms do not allow for a right of return except for matters related to any manufacturing defects on our part.  The Company recognizes licensing and development revenues in accordance with the contractual terms of the agreements.

Recent Accounting Pronouncements

 

In July 2013, the FASB issued ASC 2013-11, “Income Taxes — Presentation of an Unrecognized Tax benefit When a Net Operation Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”  (“ASU 2013-11”) which is part of Accounting Standards Codification (“ASC”) 740: Income Taxes.  The new guidance requires and entity to present an unrecognized tax benefit and an NOL carryforward, a similar tax loss or a tax credit carryforward on a net basis as part of a deferred tax asset, unless the unrecognized tax benefit is not available to reduce the deferred tax asset component or would not be utilized for that purpose, then a liability would be recognized.  ASU 2013-11 is effective for annual and interim periods for fiscal years beginning after December 15, 2013.  The Company adopted this new standard for the fiscal year ended March 31, 2015 and the adoption has not had a significant impact on its financial statements.

 

In May 2014, the FASB issued ASU 2014-9 “Revenue from Contracts with Customers (Topic 606).” This guidance requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance is effective for annual reporting periods beginning after December 15, 2016 and early adoption is not permitted. The Company will adopt this standard in fiscal year 2018. The Company has not yet determined the effect, if any, that the adoption of this standard will have on the Company’s financial position or results of operation.

 

There are currently no other accounting standards that have been issued but not yet adopted by the Company that will have a significant impact on the Company’s financial position, results of operations or cash flows upon adoption.

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

 

 

 

 

June 30,

 

 

 

2014

 

2013

 

Common stock options and warrants

 

8,090,878

 

9,338,045

 

 

 

 

 

 

June 30,
2014

 

March 31,
2014

 

Raw materials and supplies

 

$

28,702

 

$

35,543

 

Work in process

 

44,708

 

25,611

 

Finished goods

 

112,498

 

91,663

 

 

 

$

185,908

 

$

152,817

 

 

 

 

 

 

Years

 

Machinery and equipment

 

3—15

 

Furniture and fixtures

 

3—10

 

Engineering equipment

 

5—12

 

 

INTANGIBLE ASSETS (Tables)

 

 

 

 

 

 

June 30,

 

March 31,

 

 

 

Life

 

2014

 

2014

 

Patents, gross

 

6.75 – 19.46

 

$

8,135,063

 

$

8,135,063

 

In-process research and development

 

Indefinite

 

2,250,435

 

2,250,435

 

 

 

 

 

10,385,498

 

10,385,498

 

Accumulated amortization

 

 

 

1,338,359

 

1,144,858

 

Net intangible assets

 

 

 

$

9,047,139

 

$

9,240,640

 

 

 

 

Fiscal Year Ending

 

 

 

Nine months ending March 31, 2015

 

$

581,301

 

March 31, 2016

 

775,011

 

March 31, 2017

 

775,011

 

March 31, 2018

 

775,011

 

March 31, 2019

 

775,011

 

Thereafter

 

$

3,115,359

 

 

SHARE-BASED COMPENSATION (Tables)

 

 

Options

 

Shares

 

Weighted-
Average Exercise
Price

 

Weighted-Average
Remaining
Contractual Term

 

Options Outstanding March 31, 2014

 

4,342,500

 

$

0.77

 

1.75

 

Granted

 

 

 

 

Exercised

 

 

 

 

Expired/cancelled

 

(1,818,417

)

0.87

 

 

Options Outstanding June 30, 2014

 

2,524,083

 

$

0.69

 

1.49

 

Exercisable at June 30, 2014

 

2,049,708

 

$

0.77

 

1.35

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Grant-Date

 

Non-vested Shares

 

Shares

 

Fair Value

 

Non-vested at March 31, 2014

 

2,414,792

 

0.49

 

Granted

 

 

 

 

Vested

 

(122,000

)

0.43

 

Expired/cancelled: non-vested

 

(1,818,417

)

0.56

 

Non-vested at June 30, 2015

 

474,375

 

$

0.23

 

 

 

 

 

 

Options Outstanding

 

Options Exercisable

 

Range of
Exercise Price

 

Number
Outstanding

 

Weighted Average
Remaining
Contractual Life
(years)

 

Weighted Average
Exercise Price

 

Number of
Shares

 

Weighted Average
Exercise Price

 

$0.83 - $1.02

 

885,333

 

1.61

 

$

0.92

 

885,333

 

$

0.92

 

$0.70 - $0.80

 

982,500

 

1.17

 

0.71

 

940,500

 

0.71

 

$0.33 - $0.42

 

656,250

 

2.24

 

0.36

 

223,875

 

0.41

 

 

 

2,524,083

 

1.49

 

$

0.69

 

2,049,708

 

$

0.77

 

 

INVESTMENT IN JOINT VENTURE (Tables)

 

 

Balance of ownership interest in joint venture at March 31, 2014

 

$

(313,184

)

Aggregate 2015 equity loss — share of joint venture losses

 

(204,042

)

2015 equity loss — share of joint venture losses not recognized due to basis limitation

 

204,042

 

Balance of ownership interest in joint venture at June 30, 2014

 

$

 

 

 

 

 

Cumulative unrecognized loss on ownership interest in joint venture at June 30, 2014

 

$

(517,226

)

 

 

 

Revenues

 

$

 

Expenses

 

680,141

 

Net Income (Loss)

 

$

(680,141

)

 

 

 

 

Total Assets

 

$

69,597

 

 

 

 

 

Total Liabilities

 

$

1,792,382

 

Total Partners Capital

 

(1,722,786

)

Total Liabilities and Partner Capital

 

$

69,597

 

 

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Mar. 31, 2014
Antidilutive securities excluded from the calculation of diluted net loss per share
 
 
 
Common stock options and warrants excluded from the calculation of diluted net loss per share (in shares)
8,090,878 
9,338,045 
 
Other Receivables
 
 
 
Other receivables
 
 
$ 89,192 
Inventories
 
 
 
Raw materials and supplies
28,702 
 
35,543 
Work in process
44,708 
 
25,611 
Finished goods
112,498 
 
91,663 
Inventory, net
185,908 
 
152,817 
Inventory reserves
$ 68,723 
 
 
Machinery and equipment |
Minimum
 
 
 
Property, Plant and Equipment
 
 
 
Estimated useful lives
3 years 
 
 
Machinery and equipment |
Maximum
 
 
 
Property, Plant and Equipment
 
 
 
Estimated useful lives
15 years 
 
 
Furniture and fixtures |
Minimum
 
 
 
Property, Plant and Equipment
 
 
 
Estimated useful lives
3 years 
 
 
Furniture and fixtures |
Maximum
 
 
 
Property, Plant and Equipment
 
 
 
Estimated useful lives
10 years 
 
 
Engineering equipment |
Minimum
 
 
 
Property, Plant and Equipment
 
 
 
Estimated useful lives
5 years 
 
 
Engineering equipment |
Maximum
 
 
 
Property, Plant and Equipment
 
 
 
Estimated useful lives
12 years 
 
 
Leasehold improvements |
Minimum
 
 
 
Property, Plant and Equipment
 
 
 
Estimated useful lives
3 years 
 
 
Leasehold improvements |
Maximum
 
 
 
Property, Plant and Equipment
 
 
 
Estimated useful lives
7 years 
 
 
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) (USD $)
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Intangible Assets
 
 
Impairment charges
$ 0 
$ 0 
INTANGIBLE ASSETS (Details) (USD $)
3 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Mar. 31, 2014
INTANGIBLE ASSETS
 
 
 
Gross intangible assets
$ 10,385,498 
 
$ 10,385,498 
Accumulated amortization
1,338,359 
 
1,144,858 
Net intangible assets
9,047,139 
 
9,240,640 
Amortization expense
193,710 
193,753 
 
In-process research and development
 
 
 
INTANGIBLE ASSETS
 
 
 
Acquired finite lived intangible assets
2,250,435 
 
2,250,435 
Patent
 
 
 
INTANGIBLE ASSETS
 
 
 
Acquired finite lived intangible assets
$ 8,135,063 
 
$ 8,135,063 
Patent |
Minimum
 
 
 
INTANGIBLE ASSETS
 
 
 
Amortization period
6 years 9 months 
 
 
Patent |
Maximum
 
 
 
INTANGIBLE ASSETS
 
 
 
Amortization period
19 years 5 months 16 days 
 
 
INTANGIBLE ASSETS (Details 2) (USD $)
Jun. 30, 2014
Estimated annual amortization expense of intangible assets
 
Nine months ending March 31, 2015
$ 581,301 
2016
775,011 
2017
775,011 
2018
775,011 
2019
775,011 
Thereafter
$ 3,115,359 
NOTES PAYABLE (Details) (USD $)
3 Months Ended 0 Months Ended 0 Months Ended
Jun. 30, 2014
Line of Credit
Oct. 11, 2013
Line of Credit
Jun. 30, 2013
Line of Credit
Jun. 30, 2014
Line of Credit
Maximum
Oct. 11, 2013
Amended Loan Agreement
Oct. 11, 2013
Amended Loan Agreement
Oct. 11, 2013
Additional Loan
Oct. 11, 2013
Additional Loan
Notes payable
 
 
 
 
 
 
 
 
Maximum borrowing capacity
 
 
$ 1,000,000 
 
 
 
 
 
Annual interest rate (as a percent)
18.00% 
 
 
 
 
18.00% 
 
 
Service charge on late payment (as a percent)
3.00% 
 
 
 
 
 
 
 
Accommodation fees (as a percent)
 
 
 
10.00% 
 
 
 
 
Periodic collateral monitoring fee for the first six months
2,000 
 
 
 
 
 
 
 
Periodic collateral monitoring fee for the last six months
1,000 
 
 
 
 
 
 
 
Additional borrowing capacity
 
 
 
 
500,000 
 
 
 
Loan draw
 
 
 
 
 
 
280,750 
 
Applicable fees
 
 
 
 
 
 
 
30,750 
Interest reserve established
 
90,000 
 
 
 
 
 
133,500 
Accommodation fees
 
 
 
 
25,000 
 
 
 
Closing fees
 
 
 
 
3,250 
 
 
 
Financing costs capitalized
 
150,750 
 
 
 
 
 
 
Outstanding balance
$ 1,473,345 
 
 
 
 
 
 
 
Percentage increase in interest rate on the note in default status
3.00% 
 
 
 
 
 
 
 
Notice period to increase the interest rate of loan in default status
30 days 
 
 
 
 
 
 
 
CAPITAL STOCK (Details) (USD $)
3 Months Ended 0 Months Ended 0 Months Ended 3 Months Ended 0 Months Ended
Jun. 30, 2014
Mar. 31, 2014
Jun. 22, 2014
Rights Agreement
Apr. 15, 2014
Rights Agreement
Apr. 15, 2014
Rights Agreement
Apr. 12, 2014
Mr. Cunningham
Jun. 30, 2014
Mr. Cunningham
Jun. 30, 2014
Mr. Cunningham
Jun. 20, 2014
Mr. Michael Laub
Jun. 23, 2014
Settlement agreement
Messrs. Adams and Monahan
CAPITAL STOCK
 
 
 
 
 
 
 
 
 
 
Common shares, authorized
75,000,000 
75,000,000 
 
 
 
 
 
 
 
 
Common stock, par value (in dollars per share)
$ 0.001 
$ 0.001 
 
 
$ 0.001 
 
 
 
 
 
Common stock issued in exchange for consulting services per month
 
 
 
 
 
$ 4,000 
 
 
 
 
Common stock issued in exchange for consulting services per month (in shares)
 
 
 
 
 
20,000 
 
 
 
 
Common stock issued in exchange for consulting services (in shares)
60,000 
 
 
 
 
 
60,000 
 
 
 
Common stock price in exchange for consulting services (in dollars per shares)
 
 
 
 
 
 
$ 0.44 
$ 0.44 
 
 
Common stock issued in exchange for consulting services
$ 26,200 
 
 
 
 
 
 
$ 26,200 
 
 
Number of common stock purchase right declared as dividend for each share of common stock
 
 
 
 
 
 
 
 
 
Shares of common stock that can be purchased from each right
 
 
 
 
 
 
 
 
 
Exercise price (in dollars per share)
$ 1.53 
 
 
 
$ 1.20 
 
 
 
 
 
Minimum percentage of outstanding common stock to be acquired to be considered an "Acquiring Person" following issuance of rights agreement
 
 
 
0.17 
 
 
 
 
 
 
Minimum percentage of outstanding common stock to be acquired not to be considered an "Acquiring Person" before issuance of rights agreement
 
 
 
0.17 
 
 
 
 
 
 
Threshold percentage ownership of common stock required for rights to be exercisable
 
 
 
17.00% 
 
 
 
 
 
 
Shares of restricted stock issued upon appointment to the Board
 
 
 
 
 
 
 
 
50,000 
 
Shares forfeited
 
 
 
 
 
 
 
 
 
1,000,000 
Common stock, issued (in shares)
49,849,312 
50,739,312 
 
 
 
 
 
 
 
 
Common stock, outstanding (in shares)
49,849,312 
50,739,312 
 
 
 
 
 
 
 
 
Shares held in treasury
1,000,000 
1,000,000 
 
 
 
 
 
 
 
 
Warrants outstanding
5,566,795 
 
 
 
 
 
 
 
 
 
Warrants issued (in shares)
 
 
 
 
 
 
 
 
 
SHARE-BASED COMPENSATION (Details) (Stock options, USD $)
3 Months Ended 12 Months Ended
Jun. 30, 2014
item
Jun. 30, 2013
Mar. 31, 2014
May 7, 2012
Share-based compensation
 
 
 
 
Number of equity-based compensation plans
 
 
 
Number of shares of common stock authorized under the 2012 Share Incentive Plan
 
 
 
5,000,000 
Options
 
 
 
 
Options outstanding at the beginning of the period (in shares)
4,342,500 
 
 
 
Expired/Cancelled (in shares)
(1,818,417)
 
 
 
Options outstanding at the end of the period (in shares)
2,524,083 
 
4,342,500 
 
Options exercisable at the end of the period (in shares)
2,049,708 
 
 
 
Weighted Average Exercise Price
 
 
 
 
Options outstanding at the beginning of the period (in dollars per share)
$ 0.77 
 
 
 
Expired/cancelled (in dollars per share)
$ 0.87 
 
 
 
Options outstanding at the end of the period (in dollars per share)
$ 0.69 
 
$ 0.77 
 
Options exercisable at the end of the period (in dollars per share)
$ 0.77 
 
 
 
Weighted-Average Remaining Contractual Term
 
 
 
 
Options outstanding at the beginning of the period
1 year 5 months 26 days 
 
1 year 9 months 
 
Options outstanding at the end of the period
1 year 5 months 26 days 
 
1 year 9 months 
 
Exercisable at the end of the period
1 year 4 months 6 days 
 
 
 
Shares
 
 
 
 
Non-vested at the beginning of the period (in shares)
2,414,792 
 
 
 
Vested (in shares)
(122,000)
 
 
 
Expired/cancelled: non-vested (in shares)
(1,818,417)
 
 
 
Non-vested at the end of the period (in shares)
474,375 
 
2,414,792 
 
Weighted Average Grant-Date Fair Value
 
 
 
 
Non-vested at the beginning of the period (in dollars per share)
$ 0.49 
 
 
 
Vested (in dollars per share)
$ 0.43 
 
 
 
Expired/cancelled: non-vested (in dollars per share)
$ 0.56 
 
 
 
Non-vested at the end of the period (in dollars per share)
$ 0.23 
 
$ 0.49 
 
Intrinsic value of options outstanding
 
 
 
 
Intrinsic value of options outstanding
$ 0 
 
$ 0 
 
Total compensation costs
90,554 
 
 
Deferred tax asset recorded, relating to recognized compensation cost
 
 
Unrecognized compensation cost
 
 
 
 
Unrecognized compensation cost related to nonvested awards
108,979 
 
 
 
Weighted average period to recognize unrecognized compensation expense related to nonvested awards
2 years 1 month 10 days 
 
 
 
Fair value of options vested
$ 52,580 
$ 0 
 
 
Minimum
 
 
 
 
Weighted Average Exercise Price
 
 
 
 
Granted (in dollars per share)
$ 0.70 
 
 
 
Maximum
 
 
 
 
Weighted Average Exercise Price
 
 
 
 
Granted (in dollars per share)
$ 0.80 
 
 
 
SHARE-BASED COMPENSATION (Details 2) (USD $)
3 Months Ended
Jun. 30, 2014
Options Outstanding
 
Number Outstanding
2,524,083 
Weighted Average Remaining Contractual Life
1 year 5 months 26 days 
Weighted Average Exercise Price (in dollars per share)
$ 0.76 
Options Exercisable
 
Number of Shares
2,049,708 
Weighted Average Exercise Price (in dollars per share)
$ 0.77 
$0.83 - $1.02
 
Share-based compensation
 
Range of Exercise Price, low end of range (in dollars per share)
$ 0.83 
Range of Exercise Price, high end of range (in dollars per share)
$ 1.02 
Options Outstanding
 
Number Outstanding
885,333 
Weighted Average Remaining Contractual Life
1 year 7 months 10 days 
Weighted Average Exercise Price (in dollars per share)
$ 0.92 
Options Exercisable
 
Number of Shares
885,333 
Weighted Average Exercise Price (in dollars per share)
$ 0.92 
$0.70 - $0.80
 
Share-based compensation
 
Range of Exercise Price, low end of range (in dollars per share)
$ 0.70 
Range of Exercise Price, high end of range (in dollars per share)
$ 0.80 
Options Outstanding
 
Number Outstanding
982,500 
Weighted Average Remaining Contractual Life
1 year 2 months 1 day 
Weighted Average Exercise Price (in dollars per share)
$ 0.71 
Options Exercisable
 
Number of Shares
940,500 
Weighted Average Exercise Price (in dollars per share)
$ 0.71 
$0.33 - $0.42
 
Share-based compensation
 
Range of Exercise Price, low end of range (in dollars per share)
$ 0.33 
Range of Exercise Price, high end of range (in dollars per share)
$ 0.42 
Options Outstanding
 
Number Outstanding
656,250 
Weighted Average Remaining Contractual Life
2 years 2 months 26 days 
Weighted Average Exercise Price (in dollars per share)
$ 0.36 
Options Exercisable
 
Number of Shares
223,875 
Weighted Average Exercise Price (in dollars per share)
$ 0.41 
RELATED PARTIES (Details) (USD $)
0 Months Ended
May 27, 2014
Messrs. Korn
May 27, 2014
McGuire
Jun. 16, 2014
Mr. Likly
Jun. 20, 2014
Mr. Michael Laub
Jun. 22, 2014
Settlement agreement
Messrs. Korn
Jun. 22, 2014
Settlement agreement
McGuire
Jun. 22, 2014
Settlement agreement
Mr. Likly
Jun. 23, 2014
Settlement agreement
Messrs. Adams and Monahan
Related parties
 
 
 
 
 
 
 
 
Shares of restricted stock issued upon appointment to the Board
250,000 
250,000 
4,000,000 
50,000 
 
 
 
 
Amount owed for professional services
 
 
 
$ 12,000 
 
 
 
 
Value of restricted stock granted based upon liabilities owed for professional services (in dollars per share)
 
 
 
$ 0.24 
 
 
 
 
Shares of restricted stock returned
 
 
 
 
250,000 
250,000 
4,000,000 
1,000,000 
INVESTMENT IN JOINT VENTURE (Details) (USD $)
0 Months Ended 3 Months Ended 9 Months Ended
Sep. 16, 2013
item
Jun. 30, 2014
Jun. 30, 2014
Sep. 16, 2013
Investment in joint venture
 
 
 
 
Licensing revenue
 
$ 375,000 
 
 
Grace Rich Agreements |
Minimum
 
 
 
 
Investment in joint venture
 
 
 
 
Ownership percentage in joint venture
30.00% 
 
 
30.00% 
Grace Rich Limited
 
 
 
 
Investment in joint venture
 
 
 
 
Minimum number of Company designed diamond growing machines to be deployed in joint venture
100 
 
 
 
Ownership percentage in joint venture
 
 
 
30.00% 
Licensing fees under license agreement
 
 
250,000 
 
Development fees under license agreement
 
 
750,000 
 
Licensing fees per machine per month upon commencement of operation
 
250 
 
 
Minimum licensing fees upon commencement of operation
 
25,000 
 
 
Licensing revenue
 
375,000 
 
 
Reimbursable joint venture related expense
 
72,555 
 
 
Rollforward of the Company's ownership interest in the joint venture
 
 
 
 
Balance of ownership interest in joint venture, beginning balance
(313,184)
 
 
Aggregate 2015 equity loss - share of joint venture losses
 
(204,042)
 
 
2015 equity loss - share of joint venture losses not recognized due to basis limitation
 
204,042 
 
 
Cumulative unrecognized loss on ownership interest in joint venture at June 30, 2014
 
(517,226)
(517,226)
 
Selected financial results
 
 
 
 
Expenses
 
680,141 
 
 
Net Income (Loss)
 
(680,141)
 
 
Total Assets
 
69,597 
69,597 
 
Total Liabilities
 
1,792,382 
1,792,382 
 
Total Partners Capital
 
(1,722,786)
(1,722,786)
 
Total Liabilities and Partner Capital
 
$ 69,597 
$ 69,597 
 
Grace Rich Limited |
SAAMABA, LLC
 
 
 
 
Investment in joint venture
 
 
 
 
Ownership percentage in joint venture
60.00% 
 
 
60.00% 
Grace Rich Limited |
S21 Holdings
 
 
 
 
Investment in joint venture
 
 
 
 
Ownership percentage in joint venture
10.00% 
 
 
10.00% 
LITIGATION (Details) (USD $)
3 Months Ended 0 Months Ended 0 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Mar. 31, 2014
Jun. 23, 2014
Settlement agreement
Messrs. Adams and Monahan
Jun. 22, 2014
Settlement agreement
Messrs. Korn
Jun. 22, 2014
Settlement agreement
McGuire
Jun. 22, 2014
Settlement agreement
Mr. Likly
Jun. 23, 2014
Settlement agreement
Adams Group and the Save Scio Group
item
Mar. 31, 2014
Settlement agreement
Adams Group and the Save Scio Group
Jun. 23, 2014
Settlement agreement
The Save Scio Group
Jul. 26, 2013
ADI
Jul. 26, 2013
ADGC
Jul. 26, 2013
ADI and ADGC
Litigation
 
 
 
 
 
 
 
 
 
 
 
 
 
Maximum number of shares that can be acquired
 
 
 
 
 
 
 
 
 
 
16,000,000 
1,000,000 
 
Common stock, par value (in dollars per share)
$ 0.001 
 
$ 0.001 
 
 
 
 
 
 
 
 
 
$ 0.01 
Shares of restricted stock returned
 
 
 
1,000,000 
250,000 
250,000 
4,000,000 
 
 
 
 
 
 
Number of directors in expanded size of board
 
 
 
 
 
 
 
 
 
 
 
 
Period for which counterparty to the agreement must vote their shares of Common Stock for the other's nominees
 
 
 
 
 
 
 
3 years 
 
 
 
 
 
Shares of common stock to be transferred to counterparty
 
 
 
 
 
 
 
 
 
1,000,000 
 
 
 
Accrued liabilities
$ 639,942 
 
$ 573,126 
 
 
 
 
 
$ 232,806 
 
 
 
 
Consulting and expenses professional fees due to the settling parties reversed
$ 78,816 
$ (156,815)
 
 
 
 
 
$ 343,556 
 
 
 
 
 
SUBSEQUENT EVENTS (Details) (Subsequent events, Accredited investors, USD $)
1 Months Ended
Aug. 8, 2014
Jul. 15, 2014
Subsequent events
 
 
Share price (in dollars per share)
 
$ 0.30 
Number of shares of common stock issued
750,000 
 
Value of common stock issued under the offering
$ 225,000 
 
Maximum
 
 
Subsequent events
 
 
Number of shares of common stock approved for issuance
 
2,000,000 
Potential amount raised from offering
 
$ 600,000